ABHD6
Basic information
Region (hg38): 3:58237532-58295693
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABHD6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 14 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 14 | 0 | 0 |
Variants in ABHD6
This is a list of pathogenic ClinVar variants found in the ABHD6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-58256608-A-T | not specified | Uncertain significance (Aug 12, 2021) | ||
3-58256621-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
3-58256689-A-C | not specified | Uncertain significance (Nov 30, 2022) | ||
3-58267221-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
3-58267295-A-C | not specified | Uncertain significance (Mar 31, 2024) | ||
3-58269330-A-G | not specified | Uncertain significance (Oct 27, 2021) | ||
3-58269367-A-G | not specified | Uncertain significance (Oct 05, 2023) | ||
3-58270986-A-G | not specified | Uncertain significance (Jun 17, 2024) | ||
3-58274711-G-C | not specified | Uncertain significance (Sep 29, 2022) | ||
3-58274720-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
3-58274820-C-T | Benign (Dec 13, 2017) | |||
3-58285110-G-A | not specified | Uncertain significance (Mar 20, 2024) | ||
3-58285126-C-A | not specified | Uncertain significance (Dec 17, 2023) | ||
3-58285134-G-A | not specified | Uncertain significance (Dec 02, 2022) | ||
3-58285415-A-G | not specified | Uncertain significance (May 30, 2024) | ||
3-58293598-G-A | not specified | Uncertain significance (Sep 14, 2023) | ||
3-58293643-G-T | not specified | Uncertain significance (Dec 16, 2022) | ||
3-58293742-G-C | not specified | Uncertain significance (May 30, 2023) | ||
3-58293743-A-G | not specified | Uncertain significance (Oct 04, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABHD6 | protein_coding | protein_coding | ENST00000478253 | 8 | 58188 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000223 | 0.915 | 125728 | 0 | 20 | 125748 | 0.0000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.763 | 167 | 197 | 0.847 | 0.0000109 | 2216 |
Missense in Polyphen | 49 | 60.207 | 0.81385 | 636 | ||
Synonymous | 0.423 | 74 | 78.8 | 0.939 | 0.00000459 | 657 |
Loss of Function | 1.62 | 10 | 17.2 | 0.580 | 8.17e-7 | 200 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000868 | 0.0000868 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000115 | 0.000114 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Lipase that preferentially hydrolysis medium-chain saturated monoacylglycerols including 2-arachidonoylglycerol (PubMed:22969151). Through 2-arachidonoylglycerol degradation may regulate endocannabinoid signaling pathways. May also have a lysophosphatidyl lipase activity with a preference for lysophosphatidylglycerol among other lysophospholipids (By similarity). {ECO:0000250|UniProtKB:Q8R2Y0, ECO:0000269|PubMed:22969151}.;
- Pathway
- Retrograde endocannabinoid signaling - Homo sapiens (human);Signaling by GPCR;Signal Transduction;Effects of PIP2 hydrolysis;Platelet activation, signaling and aggregation;Arachidonate production from DAG;Hemostasis;triacylglycerol degradation;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.419
Intolerance Scores
- loftool
- 0.448
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.09
Haploinsufficiency Scores
- pHI
- 0.0485
- hipred
- N
- hipred_score
- 0.394
- ghis
- 0.623
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.179
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Abhd6
- Phenotype
Gene ontology
- Biological process
- phospholipid catabolic process;negative regulation of cell migration;acylglycerol catabolic process;positive regulation of lipid biosynthetic process;long-term synaptic depression;negative regulation of cold-induced thermogenesis;regulation of endocannabinoid signaling pathway
- Cellular component
- mitochondrion;plasma membrane;integral component of membrane;AMPA glutamate receptor complex;glutamatergic synapse;GABA-ergic synapse;integral component of postsynaptic membrane
- Molecular function
- phospholipase activity;acylglycerol lipase activity